Gossamer Bio, Inc. (GOSS) vs iBio, Inc. (IBIO)
A side-by-side comparison of Gossamer Bio, Inc. and iBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOSS
Gossamer Bio, Inc.
$10.69HealthcareDelayed quote: Oct 6, 2026, 3:08 PM EDT
IBIO
iBio, Inc.
$1.04HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
Total return — GOSS vs IBIO
growth of $100 · dividends reinvested · last 8yGOSS -99.3% (-45.8%/yr)IBIO -99.8% (-53.0%/yr)GOSS compounded faster over this window
GOSS IBIO
GOSS vs IBIO: by the numbers
- •IBIO is the larger company ($67M vs $65M market cap).
- •Both run net losses; GOSS's is the smaller (-235.00% vs -33044.00% net margin).
Metrics side by side
Valuation
| Metric | GOSS | IBIO |
|---|---|---|
| P/S ratio | 1.23 | 665.58 |
| P/B ratio | N/A | 0.78 |
Profitability
| Metric | GOSS | IBIO |
|---|---|---|
| Gross margin | 99.56% | 100.00% |
| Operating margin | -336.81% | -35141.00% |
| Net margin | -235.00% | -33044.00% |
| ROE | N/A | -38.55% |
| ROIC | N/A | -40.22% |
Growth (annualized)
| Metric | GOSS | IBIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -46.91% |
| Total return CAGR (5Y) | -59.51% | -70.43% |
Frequently asked
- How have GOSS and IBIO total returns compared?
- Over the past 5 years, GOSS delivered -59.51% and IBIO delivered -70.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.